Search Login Register
Oxidopamine
(6 Hydroxydopamine)
Summary
Description:
A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
Also Known As:
6 Hydroxydopamine; 6-Hydroxydopamine; Oxidopamine Hydrobromide; Oxidopamine Hydrochloride; Hydrobromide, Oxidopamine Show All >>
Networked: 1682
relevant articles (55 outcomes,
240 trials/studies)
for this Bio-Agent
Key Diseases for which Oxidopamine is
Relevant
-
Parkinson Disease (Parkinson's Disease)
:
21 outcomes 135 studies in 696 results
-
Neuroblastoma
:
7 outcomes 25 studies in 121 results
-
Hypertension (High Blood Pressure)
:
3 outcomes 4 studies in 65 results
-
Seizures (Seizure)
:
3 outcomes in 55 results
-
Nerve Degeneration
:
2 outcomes 4 studies in 16 results
Show All >>
Drugs Related to Oxidopamine
-
Dopamine (Intropin)
-
Haloperidol (Haldol)
-
Hydrogen Peroxide (Hydroperoxide)
-
1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)
-
Amphetamine (Amfetamine)
-
Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
-
Neurotoxins
-
Methamphetamine (Desoxyn)
-
Norepinephrine (Noradrenaline)
-
Glial Cell Line-Derived Neurotrophic Factor (GDNF)
Show All >>
Therapies Related to Oxidopamine
-
Transplants (Transplant)
-
Transplantation (Transplant Recipients)
-
Injections
-
Chemical Sympathectomy
-
Ligation
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.